Estech

San Ramon, United States Founded: 1996 • Age: 30 yrs Acquired By AtriCure
RF ablation devices for atrial fibrillation treatment are provided.

About Estech

Estech is a Healthcare company based in San Ramon (United States) founded in 1996, and was acquired by AtriCure in December 2013. RF ablation devices for atrial fibrillation treatment are provided. Estech has raised $39 million across 3 funding rounds from investors including AtriCure, Waveland Capital Group and Saints Capital. The company was acqui-hired. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include AtaCor Medical, Kestra Medical Technologies and CardioFocus; 3 of its 3 listed competitors have raised funding.

Company details

Estech was founded in 1996 in San Ramon, United States, and operated in the medical devices sector for cardiac surgery. A portfolio of minimally invasive and hybrid ablation devices was offered, including temperature-controlled RF energy delivery, Versapolar technology for bipolar and monopolar energy, suction-applied tissue contact, and internally-cooled options. The company was acquired by AtriCure in 2013.

  • Headquarters San Ramon, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website estech.com
  • Social LinkedIn
  • Acquired by AtriCure (Dec 2013)
Key Metrics
  • Total Equity Funding
    $39M (USD)

    in 3 rounds

  • Latest Funding Round
    $8.5M (USD), Series C

    Dec 2010

  • Investors
    AtriCure

    & 5 more

  • Acquired by
    AtriCure

    (Dec 2013)

Funding Insights of Estech

Estech has successfully raised a total of $39M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $8.5 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $39M
  • Total Rounds 3
  • Last Round Series C β€” $8.5M
  • First Round $11.2M

    (Dec 2008)

  • Investors Count 5

All 3 funding rounds of Estech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2010$8.5MSeries C––
Jun 2009$19.3MSeries C––
Dec 2008$11.2MSeries B––
Valuation history

6 investors in total: 6 institutional.

Investors in Estech

Estech has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include AtriCure, Waveland Capital Group and Saints Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Direct secondary investments are made in private company shares.
saintscapital.comDenver, United States
Venture capital firm focused on life science, medical device and healthcare companies
thpartners.netSan Francisco, United States
Healthcare investments are made by Tullis Health Investors.
tullisfunds.comPalm Beach Gardens, United States
Stage Capital is focused on private equity investments.
stagecap.comLondon, United Kingdom
Firm focused on oil and gas exploration and production
2000wavelandgroup.comIrvine, United States
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
2000atricure.comMason, United States
Premium access

Investor details for Estech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Estech

4 dated milestones of Estech across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Estech is founded.
  2. Funding First funding round of $11.2M.
  3. Funding Latest funding round, Series C, of $8.5M.
  4. Exit Acquired by AtriCure.

Competitors of Estech

Estech has 3 listed competitors in our database, 3 of them funded. They include AtaCor Medical, Kestra Medical Technologies and CardioFocus.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
atacor.com2014San Clemente, United States$136.8M15
An implantable pacemaker system is developed for cardiac pacing therapy.
kestramedical.com2014Kirkland, United States$196M118
Medical devices are developed to support cardiovascular patients at risk.
cardiofocus.com1990Marlborough, United States$260.86M105
Endoscopic catheter for atrial fibrillation ablation is developed.
Premium access

Detailed competitors of Estech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Estech

Websites that share an audience with Estech (estech.com).

Similar websites

Websites whose visitors overlap most with Estech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
atricure.com
21%
18.2K#1,529,838View details

Top companies in Cardiac and Vascular Disorders

3 companies that operate in the same segment as Estech (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Gene-editing therapies for coronary artery disease are developed.
2018Cambridge, Massachusetts, United StatesUSD 215.5 M255
Cardiac monitoring devices and applications are provided for heart health.
2010Mountain View, California, United StatesUSD 114.38 MUSD 6.18 M67
Therapies for lowering low-density lipoprotein cholesterol levels are developed.
1998Ann Arbor, Michigan, United StatesUSD 129.7 MUSD 332.31 M304
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Estech

Estech was founded in 1996 and raised its 1st funding round 12 years after it was founded.

Estech is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.

Estech is a funded company, having raised a total of $39M across 3 funding rounds to date. The company's 1st funding round was a Series B of $11.2M, raised on Dec 2008.

Estech was founded in 1996 in San Ramon, United States, and operated in the medical devices sector for cardiac surgery. A portfolio of minimally invasive and hybrid ablation devices was offered, including temperature-controlled RF energy delivery, Versapolar technology for bipolar and monopolar energy, suction-applied tissue contact, and internally-cooled options. The company was acquired by AtriCure in 2013.

Estech's top competitors include AtaCor Medical, CardioFocus and Kestra Medical Technologies.

Yes. Estech was acquired by AtriCure in December 2013.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available